Handbook of Complementary, Alternative, and Integrative Medicine

Education, Practice and Research Volume 4: Disease Focused Efficacy and Safety Profiles: Cardiovascular, Endocrine, Respiratory, Gastrointestinal, Renal, Arthritis and Neurology Disorders
1. Auflage 2025
ISBN: 978-1-032-35702-7
Verlag: CRC Press

Buch, Englisch, 714 Seiten, Format (B × H): 210 mm x 280 mm, Gewicht: 1480 g

Six volumes combine to make up the Handbook of Complementary, Alternative, and Integrative Medicine: Education, Practice and Research, which describes the education, practice, and research-related issues of complementary, alternative, and integrative medicine; and its efficacy and safety in treating diseases and health conditions. Further, the volumes review integrative medicine worldwide to share the best practices and experiences in education, practice, and research; identify the challenges, and suggest recommendations to overcome the identified challenges.

The 38 chapters of Volume 4 focus on the Evidence-Based Complementary, Alternative and Integrative Medicine practice in terms of efficacy and safety for managing diseases and conditions. Further, it includes 38 chapters about the efficacy and safety of Complementary, Alternative, and Integrative Medicine in the management of most common diseases and conditions.

Key Features:

- Describe the Efficacy and Safety of Evidence-based Complementary, Alternative, and Integrated Medicine from a disease-focused approach

- Covers the evidence-based practice of complementary, alternative, and integrative medicine for the most common diseases and conditions

- Presents up-to-date information on efficacy and safety of Complementary, Alternative and Integrated Medicine on the management of the most common diseases, which cover the whole body system such as cardiovascular diseases, pulmonary disorders and others

Zielgruppe

Professional Reference

Autoren/Hrsg.

Al-Worafi, Yaser Mohammed

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

Introduction. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Concepts. Part I. Cardiovascular Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Hypertension. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Hyperlipidemia. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Angina and Myocardial Infections. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Heart Failure. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Arrhythmias. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Thrombosis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Stroke. Part II Endocrine Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Diabetes Mellitus. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Thyroid disorders. Part III. Respiratory Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Asthma. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Chronic Obstructive Pulmonary Diseases (COPD). Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Rhinitis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Cystic Fibrosis. Part IV. Gastrointestinal Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Constipation. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Diarrhea. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Peptic Ulcer. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Inflammatory Bowel Disease. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Nausea & Vomiting. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Gastroesophageal Reflux Disease. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Liver diseases. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Pancreatitis. Part V. Renal Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy): kidney diseases. Evidence-based Complementary, Alternative and Integrated Medicine & (Safety): kidney diseases. Part VI. Arthritis Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Gout and Hyperuricemia. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Osteoporosis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Rheumatoid Arthritis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Osteoarthritis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Connective Tissue Disorders. Part VII. Neurological Disorders: Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Epilepsy. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Headaches. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Pain. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Parkinson disease. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Multiple Sclerosis. Evidence-based Complementary, Alternative and Integrated Medicine & (Efficacy and Safety): Alzheimer’s Disease.

Über Autor(innen)

Prof. Yaser Mohammed Al-Worafi is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, UAE (Previously known as Ajman University). He graduated with a bachelor's degree in Pharmacy (BPharm) from Sana’a University, Yemen, and obtained a Master's and PhD in Clinical Pharmacy from the Universiti Sains Malaysia (USM), Malaysia. Prof. Yaser has many postgraduate program certificates including Training to Teach in Medicine 2023 from Harvard Medical School, Harvard University; Contemporary Approaches to University Teaching from The Council of Australasian University Leaders in Learning and Teaching (CAULLT). Prof. Yaser is a fellow of the Royal Society of Public Health, UK. He has over 20 years of experience in education, practice, and research in Yemen, Saudi Arabia, the United Arab Emirates, and Malaysia. He has held various academic and professional positions including Deputy Dean for Medical Sciences College; PharmD program director, Head of Clinical Pharmacy/Pharmacy Practice department; Head of Teaching & Learning committee, Head of Training committee, head of curriculum committee, and other committees. He has authored over 100 peer-reviewed papers in international journals, book chapters, and edited more than 30 books and 1500 book chapters by Springer, Elsevier, Taylor & Francis, USA. Prof.Yaser has supervised/co-supervised PhD (3, one finished), Master's (27, 20 Finished), PharmD (33-finished), and B-Pharm (More than 120, 100 Finished) students. He is a reviewer for eight recognized international peer-reviewed journals. Prof. Yaser taught, prepared, designed, and wrote many pharmacy programs for many universities including the Master of Clinical Pharmacy/Pharmacy Practice program; PharmD program and BPharm program; internship/clerkships for Master, PharmD, and BPharm programs; more than 30 courses related to Clinical Pharmacy, Pharmacy Practice, Social Pharmacy and Patients' Care.